SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Renovar Regulatory News (MRV)

Share Price Information for Maven Renovar (MRV)

Share Price is delayed by 15 minutes
Get Live Data
53.25    0.00 (0.00%)
Bid:
53.00
Ask:
53.50
Spread: 0.50 (0.943%)
Market Cap: £68.50m
MRV Live PriceLast checked at - London Stock Exchange

Intraday Maven Renovar Share Chart

EGM Statement

12 Dec 2005 16:59

Murray VCT 2 PLC12 December 2005 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTOAUSTRALIA, CANADA, JAPAN, OR THE UNITED STATES OF AMERICA. THIS ANNOUNCEMENTDOES NOT CONSTITUTE OR FORM PART OF AN OFFER TO SELL, PURCHASE, EXCHANGE ORSUBSCRIBE FOR ANY SECURITIES OR SOLICITATION OF SUCH AN OFFER IN THE UNITEDSTATES OF AMERICA OR ANY OTHER JURISDICTION. THE SECURITIES REFERRED TO IN THISANNOUNCEMENT HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATESSECURITIES ACT OF 1933, AS AMENDED, AND WILL NOT BE OFFERED OR SOLD IN THEUNITED STATES EXCEPT PURSUANT TO AN APPLICABLE EXEMPTION FROM REGISTRATION 12 December 2005 Murray VCT 2 PLC (the "Company")Results of Extraordinary General Meeting and Court Meeting The Directors are pleased to announce that at the Extraordinary General Meetingand Court Meeting of the Company held today the resolutions proposed to effectthe merger of the Company with Murray VCT PLC and Murray VCT 3 PLC by way of aScheme of Arrangement were passed. Shareholders also resolved to authorise the Company to make market purchases ofup to 3,549,714 Shares pursuant to the Tender Offer at the Tender Price. The Directors further announce that Tenders in respect of 2,625,637 Shares weremade under the Tender Offer, representing 7.40 per cent. of the issued ordinaryshare capital. In accordance with the terms of the Tender Offer, the totalnumber of Shares to be bought back under the Tender Offer will therefore be2,625,637 Shares, representing 7.40 per cent. of the Shares in issue on theRecord Date. Accordingly, as a result of the aggregate level of tenders,applications in excess of the Basic Entitlement will be satisfied as to 100 percent. Subject to approval of the Scheme at the Court hearing scheduled for 12 January2006, it is expected that the effective date of the merger will be 13 January2006. A further announcement, to include information on the formula asset valuecalculations and the Tender Price, will be made at this time. The definitions set out on pages 3 to 6 of the Company's Circular dated 18November 2005 shall, unless the context otherwise requires, bear the samemeanings in this announcement. Enquiries Patrick Reeve 020 7422 7830Emil Gigov 020 7422 7830Close Venture Management LimitedRobert Lo 020 7710 7400Nabarro Wells & Co Limited, advisers tothe CompanyJohn West 020 7920 3150Clemmie CarrTavistock Communications The directors of the Company accept responsibility for the information relatingto the Company and its directors in this document. To the best of the knowledgeand belief of such directors (who have taken all reasonable care to ensure thatsuch is the case), the information relating to the Company and its directorscontained in this document, for which they are solely responsible, is inaccordance with the facts and does not omit anything likely to affect the importof such information. Nabarro Wells & Co Limited is acting exclusively for the Company and for no oneelse in connection with the merger and will not be responsible to anyone otherthan the Company for providing the protections afforded to clients of NabarroWells & Co Limited nor for providing advice in relation to the merger. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jan 202610:00 amRNSTransaction in Own Shares
23rd Jan 20264:29 pmRNSUnaudited Net Asset Value
20th Jan 20264:28 pmRNSTransaction in Own Shares
19th Jan 202610:03 amRNSUnaudited Net Asset Value
14th Jan 20262:16 pmRNSTransaction in Own Shares
13th Jan 202612:11 pmRNSDirector Declaration
9th Jan 20263:51 pmRNSUnaudited Net Asset Value
6th Jan 20265:02 pmRNSTransaction in Own Shares
2nd Jan 20262:16 pmRNSUnaudited Net Asset Value
2nd Jan 202612:26 pmRNSTotal Voting Rights
29th Dec 202511:59 amRNSTransaction in Own Shares
29th Dec 202511:59 amRNSTransaction in Own Shares
19th Dec 20253:39 pmRNSUnaudited Net Asset Value
18th Dec 202512:35 pmRNSTransaction in Own Shares
18th Dec 202512:35 pmRNSTransaction in Own Shares
12th Dec 20251:53 pmRNSUnaudited Net Asset Value
10th Dec 20254:00 pmRNSTransaction in Own Shares
5th Dec 20253:44 pmRNSUnaudited Net Asset Value
2nd Dec 20252:24 pmRNSUnaudited Net Asset Value
1st Dec 20253:54 pmRNSTransaction in Own Shares
1st Dec 20259:43 amRNSTotal Voting Rights
28th Nov 20254:31 pmRNSTransaction in Own Shares
21st Nov 20254:42 pmRNSTransaction in Own Shares
21st Nov 20254:32 pmRNSUnaudited Net Asset Value
18th Nov 20251:06 pmRNSReplacement Net Asset Value(s) and Factsheet
17th Nov 20254:40 pmRNSNet Asset Value(s) and Factsheet
17th Nov 20259:17 amRNSTransaction in Own Shares
10th Nov 202511:20 amRNSNet Asset Value(s)
4th Nov 202512:33 pmRNSNet Asset Value(s)
3rd Nov 202510:05 amRNSTotal Voting Rights
30th Oct 202510:33 amRNSTransaction in Own Shares
24th Oct 20252:45 pmRNSNet Asset Value(s)
22nd Oct 20253:57 pmRNSTransaction in Own Shares
20th Oct 20251:39 pmRNSNet Asset Value(s)
10th Oct 20254:26 pmRNSNet Asset Value(s)
9th Oct 20257:01 amRNSDividend Declaration
9th Oct 20257:00 amRNSHalf-year Report
1st Oct 20255:00 pmRNSNet Asset Value(s)
26th Sep 20252:02 pmRNSNet Asset Value(s)
22nd Sep 202510:54 amRNSNet Asset Value(s)
12th Sep 20254:27 pmRNSNet Asset Value(s)
9th Sep 202511:43 amRNSCompliance with Market Abuse Regulation
8th Sep 20251:12 pmRNSNet Asset Value(s)
2nd Sep 202510:56 amRNSNet Asset Value(s)
26th Aug 20252:13 pmRNSNet Asset Value(s)
19th Aug 20252:36 pmRNSDirector/PDMR Shareholding
15th Aug 20254:11 pmRNSNet Asset Value(s)
13th Aug 20255:57 pmRNSResults of Requisitioned General Meeting
13th Aug 202511:48 amRNSResults of Requisitioned General Meeting
11th Aug 202512:09 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.